Literature DB >> 20028348

Moderate alcohol consumption aggravates high-fat diet induced steatohepatitis in rats.

Yan Wang1, Helmut K Seitz, Xiang-Dong Wang.   

Abstract

BACKGROUND: Nonalcoholic steatohepatitis (NASH) develops in the absence of chronic and excessive alcohol consumption. However, it remains unknown whether moderate alcohol consumption aggravates liver inflammation in pre-existing NASH condition.
METHODS: Sprague-Dawley rats were first fed ad libitum with Lieber-DeCarli high-fat diet (71% energy from fat) for 6 weeks to induce NASH, as demonstrated previously. Afterwards, these rats were continuously fed with high-fat diet (HFD, 55% total energy from fat) or high fat plus alcohol diet (HFA, 55% energy from fat and 16% energy from alcohol) for an additional 4 weeks. Pathological lesions including fat accumulation and inflammatory foci in liver were examined and graded. Lipid peroxidation and apoptotic hepatocytes in the liver were assessed. The mRNA expressions of tumor necrosis factor-alpha (TNFalpha) and TNF receptor 1 (TNF-R1), Fas death receptor (Fas) and Fas ligant (FasL), IL-1beta and IL-12 were determined by real-time PCR. Protein levels of total and cleaved caspase-3, CYP2E1, Bax, and Bcl-2 were measured by western blotting.
RESULTS: The number of hepatic inflammatory foci and apoptotic hepatocytes were significantly increased in rats fed with HFA as compared with those in HFD-fed rats. The aggravated inflammatory response and cellular apoptosis mediated by HFA were associated with elevated mRNA expression of Fas/FasL and cleaved caspase-3 protein. Although no significant differences were observed between HFD and HFA groups, the levels of lipid peroxidation, Bax and Bcl-2 protein concentration, and mRNA levels of other inflammatory cytokines were significantly higher in these 2 groups than those in the control group.
CONCLUSIONS: These data suggest that even moderate alcohol consumption can cause more hepatic inflammation and cellular apoptosis in a pre-existing NASH condition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20028348      PMCID: PMC2950068          DOI: 10.1111/j.1530-0277.2009.01122.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  42 in total

1.  Chronic ethanol-initiated apoptosis in hepatocytes is induced by changes in membrane biogenesis and intracellular transport.

Authors:  A Slomiany; E Piotrowski; M Grabska; J Piotrowski; B L Slomiany
Journal:  Alcohol Clin Exp Res       Date:  1999-02       Impact factor: 3.455

2.  Steatohepatitis and apoptosis: therapeutic implications.

Authors:  Ariel Feldstein; Gregory J Gores
Journal:  Am J Gastroenterol       Date:  2004-09       Impact factor: 10.864

3.  NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis.

Authors:  Aileen Dela Peña; Isabelle Leclercq; Jacqueline Field; Jacob George; Brett Jones; Geoffrey Farrell
Journal:  Gastroenterology       Date:  2005-11       Impact factor: 22.682

Review 4.  Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies.

Authors:  Lando L J Koppes; Jacqueline M Dekker; Henk F J Hendriks; Lex M Bouter; Robert J Heine
Journal:  Diabetes Care       Date:  2005-03       Impact factor: 19.112

5.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

6.  Diet and risk of ethanol-induced hepatotoxicity: carbohydrate-fat relationships in rats.

Authors:  S Korourian; R Hakkak; M J Ronis; S R Shelnutt; J Waldron; M Ingelman-Sundberg; T M Badger
Journal:  Toxicol Sci       Date:  1999-01       Impact factor: 4.849

7.  Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients.

Authors:  Paulo S Ribeiro; Helena Cortez-Pinto; Susana Solá; Rui E Castro; Rita M Ramalho; Amélia Baptista; Miguel C Moura; Maria E Camilo; Cecília M P Rodrigues
Journal:  Am J Gastroenterol       Date:  2004-09       Impact factor: 10.864

8.  Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-alpha during alcohol consumption.

Authors:  Masahiro Minagawa; Qinggao Deng; Zhang-Xu Liu; Hidekazu Tsukamoto; Gunther Dennert
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

9.  Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression.

Authors:  Ali Canbay; Ariel E Feldstein; Hajime Higuchi; Nate Werneburg; Annette Grambihler; Steve F Bronk; Gregory J Gores
Journal:  Hepatology       Date:  2003-11       Impact factor: 17.425

Review 10.  Cellular and molecular mechanisms of liver injury.

Authors:  Harmeet Malhi; Gregory J Gores
Journal:  Gastroenterology       Date:  2008-05       Impact factor: 22.682

View more
  20 in total

Review 1.  Moderate ethanol ingestion and cardiovascular protection: from epidemiologic associations to cellular mechanisms.

Authors:  Maike Krenz; Ronald J Korthuis
Journal:  J Mol Cell Cardiol       Date:  2011-10-23       Impact factor: 5.000

2.  Deletion of tumor progression locus 2 attenuates alcohol-induced hepatic inflammation.

Authors:  Camilla P Stice; Sajid Hussain; Chun Liu; Lynne M Ausman; Xiang-Dong Wang; Andrew S Greenberg
Journal:  Hepatobiliary Surg Nutr       Date:  2016-02       Impact factor: 7.293

3.  Inhibition of diethylnitrosamine-initiated alcohol-promoted hepatic inflammation and precancerous lesions by flavonoid luteolin is associated with increased sirtuin 1 activity in mice.

Authors:  Bruna Paola Murino Rafacho; Camilla Peach Stice; Chun Liu; Andrew S Greenberg; Lynne M Ausman; Xiang-Dong Wang
Journal:  Hepatobiliary Surg Nutr       Date:  2015-04       Impact factor: 7.293

4.  Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob/ob mice.

Authors:  Giridhar Kanuri; Marianne Landmann; Josephine Priebs; Astrid Spruss; Marina Löscher; Doreen Ziegenhardt; Carolin Röhl; Christian Degen; Ina Bergheim
Journal:  Eur J Nutr       Date:  2015-05-24       Impact factor: 5.614

Review 5.  Insulin resistance in clinical and experimental alcoholic liver disease.

Authors:  Rotonya M Carr; Jason Correnti
Journal:  Ann N Y Acad Sci       Date:  2015-05-21       Impact factor: 5.691

6.  Regulation of the extrinsic apoptotic pathway by microRNA-21 in alcoholic liver injury.

Authors:  Heather Francis; Kelly McDaniel; Yuyan Han; Xiuping Liu; Lindsey Kennedy; Fuquan Yang; Jennifer McCarra; Tianhao Zhou; Shannon Glaser; Julie Venter; Li Huang; Phillip Levine; Jia-Ming Lai; Chang-Gong Liu; Gianfranco Alpini; Fanyin Meng
Journal:  J Biol Chem       Date:  2014-08-12       Impact factor: 5.157

7.  Limited therapeutic effect of N-acetylcysteine on hepatic insulin resistance in an experimental model of alcohol-induced steatohepatitis.

Authors:  Mashiko Setshedi; Lisa Longato; Dennis R Petersen; Martin Ronis; William C Chen; Jack R Wands; Suzanne M de la Monte
Journal:  Alcohol Clin Exp Res       Date:  2011-07-25       Impact factor: 3.455

Review 8.  Effect of chronic alcohol consumption on the development and progression of non-alcoholic fatty liver disease (NAFLD).

Authors:  Helmut K Seitz; Sebastian Mueller; Claus Hellerbrand; Suthat Liangpunsakul
Journal:  Hepatobiliary Surg Nutr       Date:  2015-06       Impact factor: 7.293

9.  Aggravation of nonalcoholic steatohepatitis by moderate alcohol consumption is associated with decreased SIRT1 activity in rats.

Authors:  André F Nascimento; Blanche C Ip; Renata A M Luvizotto; Helmut K Seitz; Xiang-Dong Wang
Journal:  Hepatobiliary Surg Nutr       Date:  2013-10       Impact factor: 7.293

10.  Low alcohol consumption increases the risk of impaired glucose tolerance in patients with non-alcoholic fatty liver disease.

Authors:  Teruki Miyake; Teru Kumagi; Masashi Hirooka; Shinya Furukawa; Osamu Yoshida; Mitsuhito Koizumi; Shin Yamamoto; Takao Watanabe; Yasunori Yamamoto; Yoshio Tokumoto; Eiji Takeshita; Masanori Abe; Kohichiro Kitai; Bunzo Matsuura; Yoichi Hiasa
Journal:  J Gastroenterol       Date:  2016-03-12       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.